SCHEMBL24599356

SCHEMBL24599356

Bc1nc(NC(=O)O)sc1C(CC)CC

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.36
POLB P06746 4/20 0.36
MEN1 O00255 2/20 0.36
KMT2A Q03164 2/20 0.36
MIF P14174 1/20 0.36
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 1/20 0.35
CYP1A2 P05177 1/20 0.35
CYP2C9 P11712 1/20 0.35
CYP2C19 P33261 1/20 0.35
HSD17B10 Q99714 1/20 0.35
MAPT P10636 2/20 0.35
PSEN1 P49768 2/20 0.35
PSEN2 P49810 2/20 0.35
APH1B Q8WW43 2/20 0.35
NCSTN Q92542 2/20 0.35
APH1A Q96BI3 2/20 0.35
PSENEN Q9NZ42 2/20 0.35
RORC P51449 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24599347 0.81 PSEN1 (0.41) NPC1RAB9ASMN1; SMN2MAPTPSEN1
SCHEMBL24624656 0.79 PSEN1 (0.40) POLBMEN1KMT2ANPC1RAB9A
SCHEMBL24599434 0.76 PSEN1 (0.41) POLBMEN1KMT2ASMN1; SMN2MAPT
SCHEMBL24624393 0.69 PIK3CD (0.46) NPC1RAB9ACYP1A2CYP2C9CYP2C19
SCHEMBL5224240 0.65 L3MBTL1 (0.54) POLBMEN1KMT2ANPC1RAB9A
SCHEMBL24599484 0.63 ALDH1A1 (0.46) ALDH1A1POLBNPC1RAB9ASMN1; SMN2
SCHEMBL16238270 0.63 RAB9A (0.64) ALDH1A1POLBMEN1KMT2ANPC1
SCHEMBL25865286 0.62 MEN1 (0.36) ALDH1A1POLBMEN1KMT2ANPC1
SCHEMBL2929059 0.62 FBP1 (0.51) ALDH1A1MEN1KMT2ANPC1RAB9A
SCHEMBL23213713 0.61 CCNE1 (0.66) ALDH1A1POLBMEN1KMT2ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230227446-A9 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NANJING ZHENGXIANG PHARMACEUTICALS CO., LTD. (CN) 2023-07-20 US disclosed
US-20220213096-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS NANJING ZHENGXIANG PHARMACEUTICALS CO LTD (CN) 2022-07-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230227446-A9 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS PI4KB, PI4KA, PIK3CD ALDH1A1 3189/4885POLB 379/4885MEN1 2593/4885
US-20220213096-A1 PHOSPHATIDYLINOSITOL 3-KINASE INHIBITORS PI4KB, PI4KA, PIK3CD ALDH1A1 3189/4885POLB 379/4885MEN1 2593/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.